Diabetic retinopathy. Assessment of severity and progression.
about
Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyThe epidemiology of epiretinal membranesOcular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes.Does vitreous fluorophotometry reflect severity of early diabetic retinopathy?Comparison of image-assisted versus traditional fundus examination.The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study.Retinopathy in a population-based studyBlood pressure, hypertension and retinopathy in a populationThe natural history of the first clinically visible features of diabetic retinopathy.Replication analysis for severe diabetic retinopathy.Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney diseaseImaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy.15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons.Genome-wide meta-analysis for severe diabetic retinopathy.Retinal thickness measured by spectral-domain optical coherence tomography in eyes without retinal abnormalities: the Beaver Dam Eye Study.Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.Incidence of self reported glaucoma in people with diabetes mellitusPrevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in South IndiaLimited joint mobility in subjects with insulin dependent diabetes mellitus: relationship with eye and kidney complications.The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye StudyMeta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and AsiansCross-sectional associations of blood elements, clotting factors, nephropathy, and retinal outcomes in long duration type 1 diabetes.Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to GlucoseThe Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.Clinical evaluation of the Allergan Humphrey 500 autorefractor and the Nidek AR-1000 autorefractorPatient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy.The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetesClinical evaluation of automated refraction in anterior chamber pseudophakia.A review of autorefractors.Objective autorefraction in posterior chamber pseudophakia.Comparative evaluation of the Allergan Humphrey 570 and Canon RK-1 autorefractors: II. Objective autorefraction in pseudophakes.The Hermann-Hering grid illusion demonstrates disruption of lateral inhibition processing in diabetes mellitus.Extent of foveal tritanopia in diabetes mellitus.Screening for diabetic retinopathy. Diabetic patients should continue to be assessed by direct ophthalmoscopy.Accuracy of a new photo-refractometer in young and adult patients.
P2860
Q28550615-88EE13FD-9191-43CC-A465-B0A33A5A9FD3Q30502683-7E76E0B9-264C-426B-B68E-78554F8FED39Q30862876-B1B35FFE-7C8B-4682-898A-6915EFA50992Q33647073-04FF2BA2-762A-48B0-BC6C-16AE1C5D2BD2Q33688177-ACE8E159-5316-4686-B594-0CE424282DADQ34163494-24597B17-2DD0-4C78-8218-B05BC9C1C943Q34163862-0CBBF866-55E7-4028-9D5C-DB900698064BQ34163918-19E3994E-EF9E-4DC9-8855-AA30D72FBAA4Q34164171-4C571D9F-CC76-4F37-83AB-6E325E1574A7Q34199515-FDC48CEB-8013-4E16-8AC8-7081D7912A33Q34498076-C43C77B4-8D6F-448F-B661-928FFCCD377EQ34558221-A7942406-529D-4782-BB45-4FE3FC8751B7Q34683802-8AE34ABB-EA12-4E57-B1E2-1497EAD1AB1EQ34994806-367EBB4E-108B-4AF2-8E39-FB237B51168CQ35085784-A4E4F9F6-340D-4E7C-9AC2-C79C1631F3AEQ35123462-2A176204-DD2A-4E91-9694-0CDA463FBA77Q35301530-C876E3FA-220E-48F3-A8DB-EA083BDB8D9CQ35316020-028A158B-5EDE-4CF1-9E2D-1B5EA8A3E600Q35627703-FF8233EC-8C21-4BCA-9CF7-EE092F4B3598Q35662645-8A9F211B-E72F-4A71-B9DE-64A723BE43E5Q36239731-4E878643-D768-4ABA-8EA1-440383B8A3D5Q36467143-1470A14C-AF4E-4335-839E-73F8C23E20CAQ37165322-8E4C33ED-292E-4B24-835B-F7E8267B8E3CQ37218851-B5295FC8-93D3-4965-BB68-CD1F7073B7FDQ37317722-72273977-48BF-4EC7-BC99-B9CD0C5BF70DQ37340704-2CC3E06C-C079-4272-9336-C94FF33CED6CQ37387208-93267CF6-D7DA-449B-85E4-90CCEAB8A3F8Q39684960-26DA91CD-2C45-4EBC-8C41-A83F77A8FFD9Q39718541-87210626-E0D2-4E0A-9AEE-21961D309743Q41869852-58104644-C858-4494-8220-C8FE0D632FB7Q41887888-608CFE3D-ADEC-4A35-AE5B-D3BB131F686BQ42066848-05DFE8E5-D4DC-4DAC-9575-236E0044F9F5Q43008568-581B055D-EB70-4E48-94B6-B6B8182847A5Q43188546-3E5B6EC9-BDF2-49FE-AFF4-71A49C94F46CQ45224236-61B59EDA-254F-4B86-B8EF-1418F2F04370
P2860
Diabetic retinopathy. Assessment of severity and progression.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Diabetic retinopathy. Assessment of severity and progression.
@en
type
label
Diabetic retinopathy. Assessment of severity and progression.
@en
prefLabel
Diabetic retinopathy. Assessment of severity and progression.
@en
P2093
P1433
P1476
Diabetic retinopathy. Assessment of severity and progression.
@en
P2093
P356
10.1016/S0161-6420(84)34374-3
P577
1984-01-01T00:00:00Z